Valuation: Bayer AG

Market Cap 53.72B 58.96B 49.73B 44.98B 84.38B 5,507B 88.32B 601B 238B 2,976B 221B 217B 9,426B P/E 2026 *
24.4x
P/E 2027 * 18.1x
Enterprise Value 83.49B 91.63B 77.28B 69.91B 131B 8,558B 137B 934B 371B 4,624B 344B 337B 14,649B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.7x
Free-Float
100%
Yield 2026 *
0.25%
Yield 2027 * 0.97%
1 day-0.82%
1 week-3.32%
Current month+8.11%
1 month+25.99%
3 months+11.57%
6 months+41.95%
Current year+47.74%
1 week 54.68
Extreme 54.68
57.38
1 month 43.3
Extreme 43.3
57.84
Current year 32.96
Extreme 32.96
57.84
1 year 26.64
Extreme 26.64
57.84
3 years 18.38
Extreme 18.378
57.84
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 69 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 A Buy

Director

1,900 0.0002%
3/18/26 A Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 A Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-3.32%+102.37%+31.92% 58.96B
-2.29%-5.34%+28.73%+128.34% 1,204B
-2.04%-5.78%+31.91%+78.34% 643B
-0.86%-3.71%+21.74%+105.02% 501B
-1.04%-1.80%+28.69%+68.01% 378B
-3.61%-9.62%+39.73%+30.53% 327B
-3.22%-5.20%+24.48%+51.30% 285B
-2.51%-4.49%-2.15%+29.67% 270B
-1.14%-6.05%+28.16%+65.35% 237B
-1.45%-0.85%+30.03%+120.72% 207B
Average -1.90%-4.29%+33.37%+70.92% 411B
Weighted average by Cap. -2.02%-4.69%+28.01%+87.11%

Financials

2026 *2027 *
Net sales 45.96B 50.45B 42.55B 38.49B 72.2B 4,712B 75.57B 514B 204B 2,546B 189B 185B 8,065B 47.22B 51.82B 43.71B 39.54B 74.17B 4,840B 77.63B 528B 210B 2,615B 194B 190B 8,285B
Net income 2.19B 2.4B 2.03B 1.83B 3.44B 224B 3.6B 24.5B 9.72B 121B 9.02B 8.83B 384B 2.91B 3.2B 2.7B 2.44B 4.57B 299B 4.79B 32.58B 12.93B 161B 11.99B 11.74B 511B
Net Debt 29.77B 32.67B 27.56B 24.93B 46.76B 3,051B 48.94B 333B 132B 1,649B 123B 120B 5,223B 26.66B 29.26B 24.68B 22.33B 41.88B 2,733B 43.84B 298B 118B 1,477B 110B 107B 4,678B
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,775
Date Price Change Volume
19/11/26 €54.68 -2.25% 2,186,834
18/11/26 €55.94 -0.36% 2,161,895
17/11/26 €56.14 -1.51% 1,978,746
16/11/26 €57.00 +0.85% 2,090,516
13/11/26 €56.52 -0.07% 1,893,501
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
54.68EUR
Average target price
60.58EUR
Spread / Average Target
+10.80%
  1. Stock Market
  2. Stocks
  3. BAYN Stock